Galectin Therapeutics Inc. (NASDAQ:GALT) was the target of a significant increase in short interest in August. As of August 15th, there was short interest totalling 918,337 shares, an increase of 42.9% from the July 29th total of 642,457 shares. Currently, 3.5% of the shares of the company are sold short. Based on an average daily […]
